Key Drivers
- Improving margins
- Positive FCF
- High leverage
AIAI Summary
ATS should be re‑rated and treated as a cyclical, execution‑sensitive automation play—recent quarters show margins and FCF can improve quickly when life‑sciences/energy backlog converts, but the investment hinges on proving several consecutive quarters of clean EBITDA/FCF and meaningful net‑debt reduction rather than one‑offs. If management fails to sustain backlog conversion or leverage remains high (or intangibles spur impairments), the stock risks rapid downside; require clear delivery (or holding above ~$32.5 on improving volume) before assuming a durable re‑rating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Improving margins
- •Positive FCF
- •High leverage
ATS shows clear operational recovery with rising margins and positive quarterly FCF but remains constrained by heavy long-term debt, large intangibles, low absolute profitability and rich valuation;
Price Behavior
Key Price Behavior Insights:
- •Below SMA
- •Bounce off support
- •Stalled at resistance
Over last month the stock has entered a short-term downtrend—trading below its ~$31 SMA after an ~8% drop from $32.83 to $30.16, but a sharp low of $27.56 and rebound to $30.16 indicates support near $27.5–$28.0 while resistance holds at $32.4–$32.8, implying volatile swings.
Sharp dip to $27.56 then recovery to $30.16 in last month indicating a quick rebound
Sentiment & News
Key News Insights:
- •Management engagement
- •Mixed analyst view
- •Neutral price target
ATS is stepping up direct investor outreach at the TD Cowen conference while analyst coverage remains mixed with a consensus "Hold."
Active investor meetings should clarify management messaging but are unlikely to materially change near-term sentiment given the split analyst ratings
Similar Companies in Industrials
Other companies in the same sector with AI ratings